Oğuz Ural, Sarıkaya Selçuk, Özyuvalı Ekrem, Şenocak Çağrı, Halis Fikret, Çiftci Mehmet, Yıldırım Yunus Emre, Bozkurt Ömer Faruk
Department of Urology, Keçiören Traning and Research Hospital, Ankara, Turkey.
Turk J Urol. 2014 Mar;40(1):52-5. doi: 10.5152/tud.2014.35033.
In the treatment of monosymptomatic nocturnal enuresis (MNE), enuretic alarm devices (EADs) are the first recommended treatment option. This study aimed to evaluate parental and child compliance with EAD treatment.
Fifty patients for whom EAD therapy was recommended were included in this study. The mean age of the patients was 10.4 years (5-16). All the patients were nursery or school children. Patients who did not return for their follow-up visits were called by phone, and verbal information were gathered about the use and performance success of the device. We documented the patients who used, and did not use the EAD with their reasons.
Nineteen (36%) patients were able to use the EAD without any problems. Eight of the remaining 31 patients didn't return for control, and they could not be get in touch with, either. Of the 23 (46%) families whom we could get a contact, 4 families did not purchase EAD due to a decrease in the number of wet nights, 4 families due to compensatory payment, and 3 families due to reluctance of one of the parents. One family reported that they gave up the EAD treatment because of the disturbing loud volume of the device. Four families reported that their children refused to use the EAD. Four families said that they could not use the EAD regularly because the device frequently did not work properly. In this study, we could not keep in touch with 16% of the patients, and 46% of the patients stopped using or did not receive this therapy.
Although EAD has been the priorly recommended alternative with its relatively higher success, and lower recurrence rates, our study demonstrated that the compliance of families with this treatment is below the expected level.
在单症状性夜间遗尿症（MNE）的治疗中，遗尿警报装置（EADs）是首先推荐的治疗选择。本研究旨在评估家长和孩子对EAD治疗的依从性。
本研究纳入了50例被推荐使用EAD治疗的患者。患者的平均年龄为10.4岁（5 - 16岁）。所有患者均为幼儿园或学校儿童。未返回进行随访的患者通过电话联系，收集关于该装置使用情况和性能成功与否的口头信息。我们记录了使用和未使用EAD的患者及其原因。
19例（36%）患者能够毫无问题地使用EAD。其余31例患者中有8例未返回进行复查，也无法与他们取得联系。在我们能够取得联系的23例（46%）家庭中，4个家庭因尿床夜数减少而未购买EAD，4个家庭因补偿性支付问题，3个家庭因父母一方不情愿而未购买。1个家庭报告称因装置音量过大令人困扰而放弃EAD治疗。4个家庭报告称他们的孩子拒绝使用EAD。4个家庭表示他们无法定期使用EAD，因为该装置经常不能正常工作。在本研究中，我们无法与16%的患者取得联系，46%的患者停止使用或未接受该治疗。
尽管EAD因其相对较高的成功率和较低的复发率一直是优先推荐的治疗方法，但我们的研究表明家庭对这种治疗的依从性低于预期水平。
